Peer-reviewed veterinary case report
Survival times and treatment outcomes in 28 dogs with insulinoma
By Polton, G A et al.·Published in The Journal of small animal practice·2007·Davies Veterinary Specialists, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Improved survival in a retrospective cohort of 28 dogs with insulinoma.
- Species:
- dog
Plain-English summary
A group of 28 dogs diagnosed with insulinoma, a type of pancreatic tumor that causes low blood sugar, were studied to see how long they lived after treatment. On average, dogs that had surgery lived about 785 days, and those who received additional medication (prednisolone) after surgery lived even longer, with an average of 1316 days. This suggests that both surgery and medication can significantly improve survival for dogs with this condition. If your dog has insulinoma, discussing surgical options and medical therapy with your vet could be beneficial.
People also search for: dog insulinoma treatment · insulinoma surgery for dogs · dog low blood sugar survival rate
Abstract
OBJECTIVES: To determine the survival times for a cohort of dogs with insulinoma and to describe the impact of medical therapy both in non-surgical cases and in surgical cases following relapse. METHODS: A retrospective study of dogs with insulinoma is presented. The Kaplan-Meier method is used to evaluate the survival characteristics of this population. RESULTS: Twenty-eight dogs were included in the study. The median survival time for all dogs was 547 days. Nineteen patients underwent partial pancreatectomy. The median survival time for this group was 785 days and for those subsequently receiving prednisolone therapy on relapse it was 1316 days. Perioperative complications are discussed. CLINICAL SIGNIFICANCE: Survival times in this study exceed those in other studies published previously. In part, this is explained by an improved remission duration following surgery compared with previous reports. More striking though is the longevity of patients following institution of medical therapy. These data give strong objective support to the role of medical therapy in the management of canine insulinoma, including following relapse after surgically induced remission.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17355606/